NCT05671107

Brief Summary

The purpose of this study is to develop a survey completed by parents, caregivers, or other informants that evaluates several important domains of functioning relevant to individuals with neurodevelopmental disorders, including autism spectrum disorder and people with genetic syndromes. Participation in this research will include assisting the research team in the development of the survey measures.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2021

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 16, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 4, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

September 19, 2024

Status Verified

February 1, 2024

Enrollment Period

2.7 years

First QC Date

December 16, 2022

Last Update Submit

September 17, 2024

Conditions

Keywords

Neurodevelopmental disordersPTENPHTSAutismOnline AssessmentNeurobehavioral

Outcome Measures

Primary Outcomes (6)

  • Social Communication Interaction

    Develop survey questions and scales related content areas for Social Communication Interactions. Social communication refers to the emergence of verbal and nonverbal skills, social interaction, and social cognition

    Baseline

  • Social Communication Interaction

    Develop survey questions and scales related content areas for Social Communication Interactions. Social communication refers to the emergence of verbal and nonverbal skills, social interaction, and social cognition

    One month follow up

  • Social Communication Interaction

    Develop survey questions and scales related content areas for Social Communication Interactions. Social communication refers to the emergence of verbal and nonverbal skills, social interaction, and social cognition

    Four month follow up

  • Daily Living Skills

    Develop questions and survey scales related to content areas of activities of daily living. Activities of daily living are activities related to personal care. They include bathing or showering, dressing, getting in and out of bed or a chair, walking, using the toilet, and eating.

    Baseline

  • Daily Living Skills

    Develop questions and survey scales related to content areas of activities of daily living. Activities of daily living are activities related to personal care. They include bathing or showering, dressing, getting in and out of bed or a chair, walking, using the toilet, and eating.

    One month follow up

  • Daily Living Skills

    Develop questions and survey scales related to content areas of activities of daily living. Activities of daily living are activities related to personal care. They include bathing or showering, dressing, getting in and out of bed or a chair, walking, using the toilet, and eating.

    Four months later

Secondary Outcomes (27)

  • Restrictive and Repetitive Behaviors

    Baseline

  • Restrictive and Repetitive Behaviors

    One month follow up

  • Restrictive and Repetitive Behaviors

    Four month follow up

  • Anxiety

    Baseline

  • Anxiety

    One month follow up

  • +22 more secondary outcomes

Study Arms (4)

PTEN - with NDD

Patients diagnosed with PTEN Hamartoma Tumor Syndrome and a neurodevelopmental disorder including but not limited to autism spectrum disorder, attention-deficit disorder / attention-deficit hyperactivity disorder, speech language disorder(s), intellectual disability, global developmental delay, oppositional defiant disorder, and / or motor or developmental disorders.

Diagnostic Test: NET

PTEN - without NDD

Patients diagnosed with PTEN Hamartoma Tumor Syndrome

Diagnostic Test: NET

Sibling Controls

Siblings related to patients with diagnosis of PTEN Hamartoma Tumor Syndrome

Diagnostic Test: NET

Unrelated Controls

Unrelated participants with no known genetic or neurodevelopmental disorder

Diagnostic Test: NET

Interventions

NETDIAGNOSTIC_TEST

Online survey measuring a variety of developmental domains including anxiety, motor, daily living skills, challenging behaviors, social communication, restrictive and repetitive behaviors, ADHD, executive functioning, mood, quality of life, and sleep

PTEN - with NDDPTEN - without NDDSibling ControlsUnrelated Controls

Eligibility Criteria

Age3 Years - 45 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Community sample

You may qualify if:

  • Has a PTEN Hamartoma Tumor Syndrome diagnosis with or without a neurodevelopment disorder
  • Access to a tablet (10+ inch screen), laptop, or desktop computer
  • Access to reliable internet
  • Able to attend to short videos (30 plus seconds)
  • Able to hear audio from a computer device
  • Able to see without corrective lenses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

John Carroll Univeristy

University Heights, Ohio, 44118, United States

Location

University Hospital South Hampton

Hampton, Southampton, S016 6YD, United Kingdom

Location

MeSH Terms

Conditions

Hamartoma Syndrome, MultipleNeurodevelopmental DisordersAutistic Disorder

Condition Hierarchy (Ancestors)

HamartomaNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMental DisordersAutism Spectrum DisorderChild Development Disorders, Pervasive

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2022

First Posted

January 4, 2023

Study Start

September 9, 2021

Primary Completion

June 1, 2024

Study Completion

June 30, 2024

Last Updated

September 19, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

Plan to upload deidentified data to Open Science Framework

Shared Documents
CSR
Time Frame
Within one year of study completion
More information

Locations